Skip to main content

Agencourt Licenses Kinase Sequencing Assays from Dana-Farber

NEW YORK, May 13 (GenomeWeb News) - Agencourt Bioscience, of Beverly, Mass., has licensed pre-validated SNP sequencing assays for kinases from Dana-Farber Cancer Institute, the company said today.


Kinases are implicated in a variety of human diseases, particularly cancer. The sequencing assays, which were developed in the laboratories of Dana-Farber cancer researchers Matthew Meyerson and William Sellers, will be offered as part of Agencourt's SNP discovery service for kinases. The company said that the service will allow analysis of kinase SNPs for "over 92 genes."


Financial terms of the agreement were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.